GlassScriptPhysician profile
Shawke A Soueidan
NPI 1093787376
$7,372.96
in general payments reported to CMS, 2019-2025
41 companies · $361 in 2025
The $361 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,939 · 2020: $2,555 · 2021: $43.17 · 2023: $114 · 2024: $360 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $636 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.87 |
| Education | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $2,379.45 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $676.80 | 2019-2024 | Ultomiris |
| Novartis Pharmaceuticals Corporation | $615.02 | 2019-2024 | |
| Supernus Pharmaceuticals, INC. | $421.43 | 2019-2020 | |
| Genzyme Corporation | $359.14 | 2019-2020 | |
| Lilly USA, LLC | $248.18 | 2019-2025 | Kisunla, Emgality |
| Ucb, INC. | $246.88 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $229.02 | 2019-2020 | |
| Genentech USA, INC. | $219.77 | 2019-2020 | |
| Emd Serono, INC. | $166.52 | 2019 | |
| Jazz Pharmaceuticals INC. | $162.26 | 2019-2020 | |
| Amgen INC. | $145.32 | 2019 | |
| Sunovion Pharmaceuticals INC. | $132.36 | 2019-2020 | |
| Eisai INC. | $125.00 | 2025 | |
| Livanova USA, INC. | $118.14 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawke Soueidan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.